OBJECTIVE—Impaired insulin-dependent glucose disposal in muscle and fat is a harbinger of type 2 diabetes, but murine models of selective insulin resistance at these two sites are conspicuous by their failure to cause hyperglycemia. A defining feature of muscle and fat vis-à-vis insulin signaling is that they both express the insulin-sensitive glucose transporter Glut4. We hypothesized that diabetes is the result of impaired insulin sig-naling in all Glut4-expressing tissues. RESEARCH DESIGN AND METHODS—To test the hypoth-esis, we generated mice lacking insulin receptors at these sites (“GIRKO ” mice), including muscle, fat, and a subset of Glut4-positive neurons scattered throughout the central nervous system. RESULTS—GIRKO mice develop di...
Peripheral insulin resistance and impaired insulin action are the primary characteristics of type 2 ...
Recent studies suggest that the serine/threonine kinase protein kinase B (PKB or Akt) is involved in...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...
Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and i...
Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and i...
Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and i...
Insulin receptor substrate-2-deficient (IRS22/2) mice develop type 2 diabetes. The purpose of this s...
AIMS/HYPOTHESIS: Although insulin resistance induces compensatory increases in beta cell mass and fu...
A key aspect of glucose homeostasis is the constant monitoring of blood glucose concentrations by sp...
This study was designed to determine whether altered glucose transporter expression is essential for...
Strategies to amplify whole-body glucose disposal are key therapies to treat type 2 diabetes. Mice t...
Insulin resistance impairs postprandial glucose uptake through glucose transporter type 4 (GLUT4) an...
Glucagon and α-cell dysfunction are critical in the development of hyperglycemia during diabetes bot...
In mammals requiring glucose as a primary energy source for the brain, blood glucose levels are tigh...
In mammals requiring glucose as a primary energy source for the brain, blood glucose levels are tigh...
Peripheral insulin resistance and impaired insulin action are the primary characteristics of type 2 ...
Recent studies suggest that the serine/threonine kinase protein kinase B (PKB or Akt) is involved in...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...
Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and i...
Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and i...
Type 2 diabetes is a complex metabolic disorder characterized by peripheral insulin resistance and i...
Insulin receptor substrate-2-deficient (IRS22/2) mice develop type 2 diabetes. The purpose of this s...
AIMS/HYPOTHESIS: Although insulin resistance induces compensatory increases in beta cell mass and fu...
A key aspect of glucose homeostasis is the constant monitoring of blood glucose concentrations by sp...
This study was designed to determine whether altered glucose transporter expression is essential for...
Strategies to amplify whole-body glucose disposal are key therapies to treat type 2 diabetes. Mice t...
Insulin resistance impairs postprandial glucose uptake through glucose transporter type 4 (GLUT4) an...
Glucagon and α-cell dysfunction are critical in the development of hyperglycemia during diabetes bot...
In mammals requiring glucose as a primary energy source for the brain, blood glucose levels are tigh...
In mammals requiring glucose as a primary energy source for the brain, blood glucose levels are tigh...
Peripheral insulin resistance and impaired insulin action are the primary characteristics of type 2 ...
Recent studies suggest that the serine/threonine kinase protein kinase B (PKB or Akt) is involved in...
Loss of first-phase insulin release is an early pathogenic feature of type 2 diabetes (T2D). Various...